A carregar...
Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia
Optimization of post‐remission therapies to maintain complete remission and prevent relapse is a major challenge in treating patients with acute myeloid leukemia (AML). Monitoring patients for measurable residual disease (MRD) is helpful to identify those at risk for relapse. Hypomethylating agents...
Na minha lista:
| Publicado no: | Am J Hematol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6593671/ https://ncbi.nlm.nih.gov/pubmed/30945331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25484 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|